Rules-Based Medicine Acquires Satoris Biomarker IP

RBM acquired biomarker-related IP for Alzheimer's disease and other central nervous system conditions.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.